No Data
No Data
Earnings Preview: LFCR to Report Financial Results Post-market on January 02
Analysts' Top Healthcare Picks: Lifecore Biomedical (LFCR), Castle Biosciences (CSTL)
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Here's Why Arquitos Capital Management Largely Exited Lifecore (LFCR)
Lifecore Biomedical (NASDAQ:LFCR) Investors Are Sitting on a Loss of 33% If They Invested Five Years Ago